Literature DB >> 9535732

Evidence for a 1 alpha,25-dihydroxyvitamin D3 receptor/binding protein in a membrane fraction isolated from a chick tibial fracture-healing callus.

A Kato1, J E Bishop, A W Norman.   

Abstract

Previous biological studies have implicated two vitamin D metabolites, 1 alpha,25(OH)2-vitamin D3[1 alpha,25(OH)2-D3] and 24R,25(OH)2-vitamin D3 [24R,25(OH)2D3] in the process of skeletal fracture-healing. While a nuclear receptor for 1 alpha,25(OH)2D3 is known to be present in osteoblast and absent in osteoclast cell lines, no systematic study has been carried out on the callus tissue which is formed during fracture-healing. The present report shows that a binding protein/receptor for 1 alpha,25(OH)2D3 resides both in a postnuclear membrane fraction and in a high speed cytosol fraction of the callus tissue obtained 10 days after imposition of a tibial fracture. The dissociation constant, KD, for 1 alpha,25(OH)2D3 was 0.83 +/- 0.34 M and 0.66 +/- 0.38 nM respectively, for the membrane and cytosol fractions. Results from a panel of steroid competition assays indicate that both receptor/binding proteins greatly prefer 1 alpha-hydroxylated ligands as compared to 1 alpha-deoxy or 24-hydroxylated ligands. The presence of 1 alpha,25(OH)2D3 receptors in the fracture-healing callus is consistent with the known biological effects of the metabolite on the fracture-healing process.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9535732     DOI: 10.1006/bbrc.1998.8318

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  A decrease in serum 1,25(OH)2D after elective hip replacement and during bone healing is associated with changes in serum iron and plasma FGF23.

Authors:  J Vaculik; L Wenchich; M Bobelyak; K Pavelka; J J Stepan
Journal:  J Endocrinol Invest       Date:  2022-01-26       Impact factor: 4.256

2.  Decrease in serum calcitriol (but not free 25-hydroxyvitamin D) concentration in hip fracture healing.

Authors:  J Vaculik; L Wenchich; M Bobelyak; K Pavelka; J J Stepan
Journal:  J Endocrinol Invest       Date:  2021-01-25       Impact factor: 4.256

3.  The Relative Expression of ERα Isoforms ERα66 and ERα36 Controls the Cellular Response to 24R,25-Dihydroxyvitamin D3 in Breast Cancer.

Authors:  Anjali Verma; D Joshua Cohen; Thomas W Jacobs; Barbara D Boyan; Zvi Schwartz
Journal:  Mol Cancer Res       Date:  2020-10-20       Impact factor: 6.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.